SINT Sintx Technologies, Inc.: Operating Margin

Corporate emblem and logo of Sintx Technologies Inc (SINT)

The development of Sintx Technologies relies on internal commercialization cycles and clinical trials, rendering the business resilient to macroeconomic shifts. Historical operating margin levels clearly demonstrate this trend, while -303.40 records a new benchmark level. Antibacterial ceramic implants form the foundation of profit, although raw material protectionism increases production costs, which is partially offset by defense contracts.

SINT: SINTX Technologies Operating Margin 07/04/2022 - 11/19/2026

Sintx Technologies Inc - analytical breakdowns and key metrics (SINT)

- share price and consensus valuation forecast:
Fundamental company analysis:SINT, Sintx Technologies, Inc.
Brand item of Sintx Technologies, Inc.

Operating margin measures cost management efficiency, showing the share of profit from core operations after deducting all variable and fixed expenses. By analyzing the operating profit percentage, an investor assesses the resilience of Sintx Technologies (SINT), where the unique properties of silicon nitride ceramics create a competitive advantage, allowing the company to maintain high profitability for B2B contracts in the medical sector.

Competitors of Sintx Technologies (SINT)

BSX (Boston Scientific Corporation Inc.) - Operating Margin|Operating Margin Edwards Lifesciences Inc.|Operating Margin RMD|Operating Sales Margin Insulet Corporation PODD|Operating Profitability Zimmer Biomet ZBH|CooperVision - Operating Profitability|ALGN - Operating Profitability|GMED: Operating Profitability|TMDX (TransMedics Corp) - Operating Sales Margin|Alphatec Holdings, Inc. - Operating Profit Rate|AORT (Artivion Corp) - Operating Margin|Operating Return on Sales Enovis Corp ENOV|Operating Profitability Integra LifeSciences Corp (IART)|Establishment Labs (ESTA) - Operating Profitability Margin|iLet Bionic Pancreas - Operating Sales Margin|Operating Margin IRADIMED CORPORATION IRMD|Embecta Corp - Operating Margin|Profitability of Operations Tandem Diabetes Care Inc TNDM|Axogen (AXGN) - Operating Profitability|Operating Profit Margin SIBN (SI-BONE Medical)|Operating Profitability orthofix.com|Operating Return on Sales bioventus.com BVS|Operating Margin KIDS|TMCI - Operating Return on Sales|Operating Profitability Strata Critical Medical Inc SRTA|CARL: Return on Sales by Operating Profit|RXST: Operating Sales Margin|clearpointneuro.com - Operating Profit Ratio|Stereotaxis Inc (STXS) - Operating Profitability|Return on Sales by Operating Profit STIM|SGHT (Sight Sciences Inc) - Operating Margin|OBIO: Operating Profit Rate|Operating Margin ANIK|Profitability of Operations inspiremd.com|Jin Medical International - Operating Sales Margin|Operating Margin Vivani Medical, Inc. VANI|XTNT: Operating Sales Margin|Operating Return on Sales NeuroOne Medical Technologies Corp.|MODD: Operating Margin|MYO - Profitability of Operations|Operating Profitability Envoy Medical Inc.|VVOS (Vivos Therapeutics, Inc.) - Operating Profit Ratio|Operating Sales Margin NVNO (enVVeno)|TNON - Operating Return on Sales|Operating Profitability ReWalk Robotics LFWD|AMIX: Return on Sales by Operating Profit|IVF - Operating Profitability|Operating Return on Sales Bone Biologics Corp|AXNX: Operating Margin|Operating Sales Margin BIOLASE, Inc.|Operating Sales Margin DYNT|Operating Sales Margin Paragon 28 (FNA)|Operating Profitability INVO Bio (INVO)